Zana Technologies GmbH

𝐙𝐚𝐧𝐚 𝐢𝐬 𝐩𝐫𝐢𝐳𝐞 𝐰𝐢𝐧𝐧𝐞𝐫 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐓𝐞𝐜𝐡 𝐰𝐢𝐭𝐡 𝐢𝐭𝐬 𝐯𝐨𝐢𝐜𝐞 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐫𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬! 🎉 Over the past three years, the pan-European URBAN TECH Project supported the acceleration of SMEs and startups by launching new or significantly improved products in the #HealthTech, Smart City, and Greentech sectors. 🚀 ⛳ Zana's remarkable journey with URBAN TECH began as part the initial 500+ applications from all over Europe, narrowed down to 160 companies selected in phase one. In each of the following 4 phases from hackathon, to MVP & pilot development and then to market discovery phase, Zana was successfully past every selection, culminating in the final pitch competition with the top 12 solution providers. 🏆The award and recognition go the entire Zana #team for the great work and care they put in building the product & technology. We are immensely grateful to our clinical partner and challenge owner, Dr. Sami Simons from Maastricht UMC+, who has become our closest collaborator and true ambassador. 👏 Special thanks to Charlene Fischer and the CyberForum team for their mentorship, and the URBAN TECH teams and experts all over Europe who contributed to this project's success.

🚀 UNISONO Milestone: Advancing Voice Biomarkers in Heart Failure Monitoring We are excited to announce a major milestone in the UNISONO project, led by Zana in collaboration with Cosinuss GmbH° and the German Center for Heart Failure at Universitätsklinikum Würzburg. 🔬 What makes this project groundbreaking? UNISONO is developing an 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐢𝐧-𝐞𝐚𝐫 𝐬𝐞𝐧𝐬𝐨𝐫 𝐭𝐡𝐚𝐭 𝐢𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐞𝐬 𝐯𝐨𝐢𝐜𝐞 𝐫𝐞𝐜𝐨𝐠𝐧𝐢𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐜𝐨𝐧𝐭𝐢𝐧𝐮𝐨𝐮𝐬 𝐯𝐢𝐭𝐚𝐥 𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠, unlocking novel #voice #biomarkers for AI-assisted clinical phenotyping in chronic heart failure. ❤️ ✅ Latest achievement: The first prototype of the in-ear sensor by cosinuss° is now complete! In addition to tracking vital signs, the device now features an integrated speaker and microphone, enabling real-time audio functionality. 📍 Start of Feasibility study The feasibility study has started at University Hospital Würzburg, where Heart Failure patients will use the device alongside Zana’s mobile #app in a three-month home study. The app with the sensor will facilitate data collection, patient interaction, and real-time monitoring, combining vital data and voice recordings to pave the way for new AI-driven insights into heart failure. We look forward to sharing more results as we continue shaping the future of AI-powered remote monitoring and voice-based digital biomarkers! #VoiceBiomarkers #HeartFailure #DigitalHealth #AI #UNISONO #MedTech #RemoteMonitoring #AISensor

🌟 𝐙𝐚𝐧𝐚 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐬 𝐈𝐒𝐎 13485 𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐟𝐨𝐫 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭🌟 Zana has officially obtained ISO 13485 certification, reinforcing its commitment to 𝐡𝐢𝐠𝐡-𝐪𝐮𝐚𝐥𝐢𝐭𝐲, 𝐬𝐚𝐟𝐞, 𝐚𝐧𝐝 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲! 🎉 At Zana, we are advancing 𝐕𝐨𝐢𝐜𝐞 𝐀𝐈-𝐝𝐫𝐢𝐯𝐞𝐧 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐨𝐧𝐬 and 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫𝐬, empowering self-management, remote care, and providing objective real-world health measures. Achieving ISO 13485 certification validates our dedication to meeting the highest medical device quality standards and brings us one step closer to regulatory approval as a medical device. 🔹 Our CEO, Dr.-Ing. Julia Hoxha, states, "𝘈𝘤𝘩𝘪𝘦𝘷𝘪𝘯𝘨 𝘐𝘚𝘖 13485 𝘤𝘦𝘳𝘵𝘪𝘧𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘮𝘢𝘳𝘬𝘴 𝘢 𝘴𝘪𝘨𝘯𝘪𝘧𝘪𝘤𝘢𝘯𝘵 𝘴𝘵𝘦𝘱 𝘪𝘯 𝘰𝘶𝘳 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘰𝘶𝘴 𝘫𝘰𝘶𝘳𝘯𝘦𝘺 𝘰𝘧 𝘣𝘳𝘪𝘯𝘨𝘪𝘯𝘨 𝘩𝘪𝘨𝘩-𝘲𝘶𝘢𝘭𝘪𝘵𝘺, 𝘈𝘐-𝘱𝘰𝘸𝘦𝘳𝘦𝘥 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘴 𝘵𝘰 𝘵𝘩𝘦 𝘮𝘢𝘳𝘬𝘦𝘵. 𝘞𝘦 𝘢𝘳𝘦 𝘤𝘰𝘮𝘮𝘪𝘵𝘵𝘦𝘥 𝘵𝘰 𝘣𝘶𝘪𝘭𝘥𝘪𝘯𝘨 𝘵𝘳𝘶𝘴𝘵𝘸𝘰𝘳𝘵𝘩𝘺, 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭𝘭𝘺 𝘷𝘢𝘭𝘪𝘥𝘢𝘵𝘦𝘥 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘵𝘩𝘢𝘵 𝘦𝘯𝘩𝘢𝘯𝘤𝘦𝘴 𝘱𝘢𝘵𝘪𝘦𝘯𝘵 𝘤𝘢𝘳𝘦, 𝘦𝘮𝘱𝘰𝘸𝘦𝘳𝘴 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘷𝘪𝘥𝘦𝘳𝘴, 𝘢𝘯𝘥 𝘮𝘦𝘦𝘵𝘴 𝘵𝘩𝘦 𝘩𝘪𝘨𝘩𝘦𝘴𝘵 𝘪𝘯𝘥𝘶𝘴𝘵𝘳𝘺 𝘴𝘵𝘢𝘯𝘥𝘢𝘳𝘥𝘴 𝘧𝘰𝘳 𝘴𝘢𝘧𝘦𝘵𝘺 𝘢𝘯𝘥 𝘦𝘧𝘧𝘦𝘤𝘵𝘪𝘷𝘦𝘯𝘦𝘴𝘴." The company is focused on securing regulatory approval, ensuring its patient engagement solutions and Voice AI-powered digital biomarkers are seamlessly integrated into clinical workflows and digital health ecosystems. We remain committed to our collaboration with healthcare providers, patients, and industry leaders to drive meaningful impact. 🚀 🔗 Press release is linked below. #ISO13485 #MedicalDevices #DigitalHealth #VoiceAI #HealthcareInnovation #QualityMatters #AIinHealthcare #RegulatoryCompliance #Zana

𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐏𝐨𝐫𝐭𝐮𝐠𝐚𝐥'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐒𝐲𝐬𝐭𝐞𝐦 🚀 Representing Zana at 𝐏𝐫𝐨𝐭𝐞𝐜𝐡𝐭𝐢𝐧𝐠 𝐌𝐚𝐭𝐜𝐡 𝐃𝐚𝐲 in Lisbon, our CEO, Dr.-Ing. Julia Hoxha, had the privilege of discussing opportunities to pilot our #voice #biomarker solution for 𝐇𝐞𝐚𝐫𝐭 𝐅𝐚𝐢𝐥𝐮𝐫𝐞 𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 and 𝐫𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧— a game-changer in digital health. It was inspiring to witness the dedication of experts from Fidelidade and 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐝𝐚 𝐋𝐮𝐳, referred to as "𝐼𝑛𝑛𝑜𝑣𝑎𝑡𝑖𝑜𝑛 𝐻𝑒𝑟𝑜𝑒𝑠", to foster 𝐡𝐞𝐚𝐥𝐭𝐡𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐢𝐧𝐬𝐮𝐫𝐭𝐞𝐜𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧. They truly lived up to this title, as they actively engaged with the teams to explore real-world collaborations and even cook together traditional Portuguese food. A highlight was the personal visit at the Hospital da Luz Learning Health, one of the largest simulation centers in Europe, where innovative technology is shaping healthcare´s future. Many thanks to Raquel Araújo and Dr. Bernardo Neves (our 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐡𝐞𝐫𝐨 in #Protechting) for the warm welcome and insightful tour! We also had a very productive meeting with Dr. Pedro Sarmento from the cardiology department, who is embracing innovative technology and recognizing the power of #Voice #AI solutions in #Heart #Failure patients. Hospital da Luz is integrated into the 𝐓𝐞𝐬𝐭 𝐁𝐞𝐝 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐭𝐰𝐨𝐫𝐤 as part of its Intelligent Health Platform (IHP). With a mission to accelerate the creation of evidence that impacts the health system, this initiative plays a crucial role in validating new healthcare solutions. We look forward to further strengthening these #partnerships and advancing impactful innovations in digital health and insurance technology. Appreciation to Fábrica de Startups S.A. for the excellent organization and ongoing support! #HealthTech #InsurTech #VoiceAI #VoiceBiomarkers #Innovation #Protechting #Collaboration

𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐏𝐨𝐫𝐭𝐮𝐠𝐚𝐥'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐒𝐲𝐬𝐭𝐞𝐦 🚀 Representing Zana at 𝐏𝐫𝐨𝐭𝐞𝐜𝐡𝐭𝐢𝐧𝐠 𝐌𝐚𝐭𝐜𝐡 𝐃𝐚𝐲 in Lisbon, our CEO, Dr.-Ing. Julia Hoxha, had the privilege of discussing opportunities to pilot our #voice #biomarker solution for 𝐇𝐞𝐚𝐫𝐭 𝐅𝐚𝐢𝐥𝐮𝐫𝐞 𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 and 𝐫𝐞𝐬𝐩𝐢𝐫𝐚𝐭𝐨𝐫𝐲 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐩𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧— a game-changer in digital health. It was inspiring to witness the dedication of experts from Fidelidade and 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥 𝐝𝐚 𝐋𝐮𝐳, referred to as "𝐼𝑛𝑛𝑜𝑣𝑎𝑡𝑖𝑜𝑛 𝐻𝑒𝑟𝑜𝑒𝑠", to foster 𝐡𝐞𝐚𝐥𝐭𝐡𝐭𝐞𝐜𝐡 𝐚𝐧𝐝 𝐢𝐧𝐬𝐮𝐫𝐭𝐞𝐜𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧. They truly lived up to this title, as they actively engaged with the teams to explore real-world collaborations and even cook together traditional Portuguese food. A highlight was the personal visit at the Hospital da Luz Learning Health, one of the largest simulation centers in Europe, where innovative technology is shaping healthcare´s future. Many thanks to Raquel Araújo and Dr. Bernardo Neves (our 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐡𝐞𝐫𝐨 in #Protechting) for the warm welcome and insightful tour! We also had a very productive meeting with Dr. Pedro Sarmento from the cardiology department, who is embracing innovative technology and recognizing the power of #Voice #AI solutions in #Heart #Failure patients. Hospital da Luz is integrated into the 𝐓𝐞𝐬𝐭 𝐁𝐞𝐝 𝐍𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐭𝐰𝐨𝐫𝐤 as part of its Intelligent Health Platform (IHP). With a mission to accelerate the creation of evidence that impacts the health system, this initiative plays a crucial role in validating new healthcare solutions. We look forward to further strengthening these #partnerships and advancing impactful innovations in digital health and insurance technology. Appreciation to Fábrica de Startups S.A. for the excellent organization and ongoing support! #HealthTech #InsurTech #VoiceAI #VoiceBiomarkers #Innovation #Protechting #Collaboration

They’re here! 🎉 We’re proud to present the startups selected for this 7th edition of Protechting. 👏 AiTecServ . Careceiver . Granter.ai . Humanos . Lampsy Health . The Loop co. . Medgical . NeuralShift . Nuada . OWLplaces . Psychomeasure . Saffe . SleepUp . Usawa Care . Zana Technologies These teams are shaping the future of healthtech and insurtech, delivering innovative solutions to tackle real-world challenges. 🌍 Congratulations to all the finalists! We can’t wait to see what’s next as we kick off this exciting journey together. 🚀 Fidelidade Fosun 复星 Hospital da Luz Learning Health #Fidelidade #Fosun #HospitaldaLuzLearningHealth #Protechting

Zana is selected to join the Protechting Program, a global innovation initiative supported by the health group Luz Saúde, Fidelidade, Fosun. This provides an opportunity for a unique test bed to validate Zana’s 𝘃𝗼𝗶𝗰𝗲 𝗯𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 with partners such as 𝘏𝘰𝘴𝘱𝘪𝘵𝘢𝘭 𝘓𝘶𝘻 𝘚𝘢𝘶𝘥𝘦, one of Portugal’s biggest private health groups. Protechting focuses on fostering transformative solutions in Insurtech, Healthtech, and AI technologies, offering startups opportunities to collaborate with major industry players, develop pilots, and secure funding. Out of over #300 applicants, Zana was chosen to collaborate with top players in healthcare and insurance. This milestone recognizes Zana's innovation in developing #voice-based AI solutions for #health monitoring and chronic disease management. As part of the program, Zana will work with healthcare and innovation experts to validate its innovative 𝘃𝗼𝗶𝗰𝗲-𝘁𝗼-𝗵𝗲𝗮𝗹𝘁𝗵 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺. The device-agnostic solution platform analyzes speech to detect health deterioration in conditions like 𝗛𝗲𝗮𝗿𝘁 𝗙𝗮𝗶𝗹𝘂𝗿𝗲 and 𝗖𝗢𝗣𝗗, offering a non-invasive alternative to costly or subjective diagnostics like spirometry and implantable devices. Zana's platform offers: ✔️ Objective #monitoring of health deterioration. ✔️ Proactive #care through timely interventions that reduce hospitalizations. ✔️ Improved patient engagement with #voice #journaling, driving adherence. With the opportunity to collaborate with industry leaders and validate its groundbreaking technology, Zana is poised to redefine chronic disease management and create meaningful impact in the healthcare landscape.

Voice changes recorded on a smartphone can indicate a flare up of COPD symptoms. Article on our TACTICAS study picked up and highlighted by the European Respiratory Society. Initial results of the study with our clinical partners at MUMC @presented these days at the ERS Congress in Vienna. Sami Simons, Loes van Bemmel

The following article summarizes the perspectives and remarks on the implications of EU´s AI Act in the healthcare sector from three experts: our CEO Dr.-Ing. Julia Hoxha, Dr. Tanja Bratan, and Dr. Andrea Sautter. The AI Act introduces a risk-based approach, where AI systems used in healthcare, particularly those classified as medical devices, are subject to strict oversight. High-risk systems will face additional rigorous requirements and conformity assessment, including data management, transparency, and human oversight. The regulation is expected to have far-reaching implications for all stakeholders, not just AI providers. 👉 Link: https://lnkd.in/eVUbbjWN Author: Dr. Anja Segschneider Published at BIOPRO Baden-Württemberg GmbH funded by the Ministry of Economic Affairs, Employment and Tourism BW. #euAIAct #regulation #healthcare #AIHealth

The following article summarizes the perspectives and remarks on the implications of EU´s AI Act in the healthcare sector from three experts: our CEO Dr.-Ing. Julia Hoxha, Dr. Tanja Bratan, and Dr. Andrea Sautter. The AI Act introduces a risk-based approach, where AI systems used in healthcare, particularly those classified as medical devices, are subject to strict oversight. High-risk systems will face additional rigorous requirements and conformity assessment, including data management, transparency, and human oversight. The regulation is expected to have far-reaching implications for all stakeholders, not just AI providers. 👉 Link: https://lnkd.in/eVUbbjWN Author: Dr. Anja Segschneider Published at BIOPRO Baden-Württemberg GmbH funded by the Ministry of Economic Affairs, Employment and Tourism BW. #euAIAct #regulation #healthcare #AIHealth